Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)

NCT00586560 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Kareniticin and cyclophosphamide

Sponsor

Baylor College of Medicine

Collaborators

[object Object]